News

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…

Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…

LUTEIN, a pigment found in kale, spinach, avocados, and eggs, may work to rejuvenate cognitive function, according to a study from the University of…

RESEARCH conducted at Kings College London, London, UK and Icahn School of Medicine, Mount Sinai, New York City, New York, USA has shown a link between…

United Kingdom, August 17, 2017: A warm welcome to the 2017 EMJ Reproductive Health eJournal! This instalment gives a complete review of…

If you haven’t been living under a rock, then I’m pretty sure you will have heard of TED, a non-profit organisation dedicated to spreading ideas, in the…

SEVERE viral and bacterial co-infection, initiating dangerous cases of pneumonia, has been the target of new drug-based treatments recently investigated…